Found: 70
Select item for more details and to access through your institution.
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 300, doi. 10.1007/s10637-021-01180-9
- By:
- Publication type:
- Article
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 1052, doi. 10.1007/s10637-019-00731-5
- By:
- Publication type:
- Article
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 225, doi. 10.1007/s10637-016-0334-y
- By:
- Publication type:
- Article
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 112, doi. 10.1007/s10637-015-0307-6
- By:
- Publication type:
- Article
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 397, doi. 10.1007/s10637-014-0199-x
- By:
- Publication type:
- Article
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1566, doi. 10.1007/s10637-011-9725-2
- By:
- Publication type:
- Article
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1426, doi. 10.1007/s10637-010-9498-z
- By:
- Publication type:
- Article
Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 455, doi. 10.1007/s10637-008-9144-1
- By:
- Publication type:
- Article
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 1, p. 59, doi. 10.1007/s10637-007-9090-3
- By:
- Publication type:
- Article
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 2, p. 135, doi. 10.1007/s10637-006-5934-5
- By:
- Publication type:
- Article
Results from a prostate cancer admixture mapping study in African-American men.
- Published in:
- Human Genetics, 2009, v. 126, n. 5, p. 637, doi. 10.1007/s00439-009-0712-z
- By:
- Publication type:
- Article
Smartphone apps for cancer: A content analysis of the digital health marketplace.
- Published in:
- Digital Health, 2020, v. 6, p. 1, doi. 10.1177/2055207620905413
- By:
- Publication type:
- Article
Smartphone apps for cancer: A content analysis of the digital health marketplace.
- Published in:
- Digital Health, 2020, p. 1, doi. 10.1177/2055207620905413
- By:
- Publication type:
- Article
Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 4, p. 802, doi. 10.3390/cells10040802
- By:
- Publication type:
- Article
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6676, doi. 10.3390/ijms22136676
- By:
- Publication type:
- Article
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Secondary Chemoprevention of Barrett's Esophagus With Cellecoxib: Results of a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 7, p. 545, doi. 10.1093/jnci/djk112
- By:
- Publication type:
- Article
Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mutations in ß-Catenin and APC Genes are Uncommon in Esophageal and Esophagogastric Junction Adenocarcinomas.
- Published in:
- Modern Pathology, 2000, v. 13, n. 10, p. 1055, doi. 10.1038/modpathol.3880194
- By:
- Publication type:
- Article
Global peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using point matching algorithms.
- Published in:
- Journal of Bioinformatics & Computational Biology, 2016, v. 14, n. 6, p. -1, doi. 10.1142/S0219720016500323
- By:
- Publication type:
- Article
Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 4, p. 655, doi. 10.1007/s10555-018-9767-4
- By:
- Publication type:
- Article
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.
- Published in:
- Cancer & Metastasis Reviews, 2016, v. 35, n. 2, p. 333, doi. 10.1007/s10555-016-9622-4
- By:
- Publication type:
- Article
Preface.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 11, p. 3209, doi. 10.1007/s11136-023-03468-0
- By:
- Publication type:
- Article
Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers.
- Published in:
- Prostate Cancer (20903111), 2012, p. 1, doi. 10.1155/2012/640968
- By:
- Publication type:
- Article
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
- Published in:
- Prostate, 2024, v. 84, n. 3, p. 292, doi. 10.1002/pros.24650
- By:
- Publication type:
- Article
<sup>18</sup>F‐sodium fluoride positron emission tomography quantitation of bone metastases in African American and non‐African American men with metastatic prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1193, doi. 10.1002/pros.24578
- By:
- Publication type:
- Article
Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian men.
- Published in:
- Prostate, 2022, v. 82, n. 6, p. 666, doi. 10.1002/pros.24310
- By:
- Publication type:
- Article
Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies.
- Published in:
- Oncologist, 2023, v. 28, p. S14, doi. 10.1093/oncolo/oyad216.024
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e815, doi. 10.1093/oncolo/oyac176
- By:
- Publication type:
- Article
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1149, doi. 10.1634/theoncologist.2019-0331
- By:
- Publication type:
- Article
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 163, doi. 10.1634/theoncologist.2012-314
- By:
- Publication type:
- Article
Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 6, p. 3325, doi. 10.1002/cam4.2092
- By:
- Publication type:
- Article
Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033729
- By:
- Publication type:
- Article
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
- By:
- Publication type:
- Article
Experience with the US health care system for Black and White patients with advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 16, p. 2532, doi. 10.1002/cncr.34885
- By:
- Publication type:
- Article
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 16, p. 2954, doi. 10.1002/cncr.33589
- By:
- Publication type:
- Article
Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 695, doi. 10.3390/biom14060695
- By:
- Publication type:
- Article
Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.1015531
- By:
- Publication type:
- Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
- Published in:
- ISRN Oncology, 2012, p. 1, doi. 10.5402/2012/242850
- By:
- Publication type:
- Article
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 1, p. e2034633, doi. 10.1001/jamanetworkopen.2020.34633
- By:
- Publication type:
- Article
Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7148
- By:
- Publication type:
- Article
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8604, doi. 10.1002/cam4.5552
- By:
- Publication type:
- Article